Table 2. Multivariate analysis of clinical prognostic factors for the development of prostate cancer recurrence and any-cause death.
Any recurrence |
Any-cause death |
|||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
All prostate cancer cases | ||||
cT stage | 1.33 (0.77–2.3) | 0.3 | 0.63 (0.26–1.56) | 0.32 |
PSA | 1.07 (0.77–1.48) | 0.7 | 0.86 (0.51–1.46) | 0.58 |
Primary Gleason⩾4 | 1.72 (1.01–2.93) | 0.048 | 2.2 (0.93–5.2) | 0.07 |
Total TOPK | 1.73 (1.02–2.92) | 0.04 | 1.65 (0.72–3.8) | 0.24 |
Abbreviations: CI=confidence interval; HR=hazard ratio; PSA=prostate specific antigen.